GURUFOCUS.COM » STOCK LIST » USA » OTCPK » THC Therapeutics Inc (OTCPK:THCT) » Definitions » Earnings Yield (Joel Greenblatt) %
Switch to:

THC Therapeutics (OTCPK:THCT) Earnings Yield (Joel Greenblatt) %

: -84.03% (As of Jul. 2022)
View and export this data going back to 2007. Start your Free Trial

THC Therapeutics's Enterprise Value for the quarter that ended in Jul. 2022 was $1.68 Mil. THC Therapeutics's EBIT for the trailing twelve months (TTM) ended in Jul. 2022 was $-1.37 Mil. THC Therapeutics's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jul. 2022 was -84.03%.

The historical rank and industry rank for THC Therapeutics's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

THCT' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -2248.03   Med: 0   Max: 2500
Current: -102.04

During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of THC Therapeutics was 2500.00%. The lowest was -2248.03%. And the median was 0.00%.

THCT's Earnings Yield (Joel Greenblatt) % is ranked worse than
91.7% of 1120 companies
in the Drug Manufacturers industry
Industry Median: 2.35 vs THCT: -102.04

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. THC Therapeutics's Forward Rate of Return (Yacktman) % for the quarter that ended in Jul. 2022 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


THC Therapeutics (OTCPK:THCT) Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for THC Therapeutics's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Earnings Yield (Joel Greenblatt) % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.30 -60.98 -76.34 -37.04 -84.03

THC Therapeutics Quarterly Data
Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22
Earnings Yield (Joel Greenblatt) % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.04 -24.57 -58.82 -294.12 -84.03

THC Therapeutics (OTCPK:THCT) Earnings Yield (Joel Greenblatt) % Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

THC Therapeutics (OTCPK:THCT) Earnings Yield (Joel Greenblatt) % Distribution

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's Earnings Yield (Joel Greenblatt) % falls into.



THC Therapeutics Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

THC Therapeuticss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jul. 2022 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-1.419/1.6821842
=-84.35 %

THC Therapeutics's EBIT for the trailing twelve months (TTM) ended in Jul. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.37 Mil.



THC Therapeutics  (OTCPK:THCT) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


THC Therapeutics Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


THC Therapeutics (OTCPK:THCT) Business Description

THC Therapeutics logo
Traded in Other Exchanges
N/A
Address
11700 W Charleston Bpulevard, Suite 73, Las Vegas, NV, USA, 89135
THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours while reducing the viability of microbial contaminants.
Executives
Tanaka Hiro director, officer: Vice President 3RD FLOOR, 207 REGENT STREET LONDON X0 W1B 3HH
Smith Adrian J R director, officer: Chair of the Board 119 SPRINGLINE DRIVE VERO BEACH FL 32963
Mann Jamie director, 10 percent owner, officer: CEO, CFO 3RD FLOOR, 207 REGENT STREET LONDON X0 W1B 3HH
Ho Eden director, officer: CEO 701 XUANG MI HU ROAD, XI YUAN, FUTIAN SHENZHEN F4 XXXXXX
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
premium membership